RV-521 (RNAimmune)

N/A

Report date: 2025/07/02 10:12:56

Base Information

Drug NameRV-521 (RNAimmune)
Drug Alias NameKRAS Vaccine (RNAimmune)RV-521
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsSkin NeoplasmsPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRNAimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesRNAimmune Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsSkin NeoplasmsPancreatic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A